|
⚲
|
| Keyboard |
| Nant Capital LLC
✚
|
|
|---|---|
| CIK # | 0001675758 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001675758] | |
| 4 | [0001675758] | |
| SC 13D | [0001675758] | |
| SC 13G | [0001675758] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Nant Capital LLC | Panbela Therapeutics Inc | [2024-10-29] |
| Nant Capital LLC | NantHealth Inc | [2023-09-07] |
| Nant Capital LLC | Heliogen Inc | [2022-02-23] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ImmunityBio Inc IBRX
Restricted Stock Units · derivative
|
2026-02-22 | Option exercise | 114,329 | $0.00 | |
|
ImmunityBio Inc IBRX
Common Stock
|
2026-02-22 | Tax withheld | 58,170 | $8.70 | 506,079 |
|
ImmunityBio Inc IBRX
Common Stock
|
2026-02-22 | Option exercise | 114,329 | $0.00 | |
|
ImmunityBio Inc IBRX
Restricted Stock Units · derivative
|
2026-02-10 | Option exercise | 274,122 | $0.00 | |
|
ImmunityBio Inc IBRX
Common Stock
|
2026-02-10 | Option exercise | 274,122 | $0.00 | |
|
ImmunityBio Inc IBRX
Common Stock
|
2026-02-10 | Tax withheld | 118,560 | $6.93 | 821,621 |
|
ImmunityBio Inc IBRX
Common Stock
|
2025-02-22 | Option exercise | 114,329 | $0.00 | |
|
ImmunityBio Inc IBRX
Common Stock
|
2025-02-22 | Tax withheld | 42,071 | $3.42 | 143,883 |
|
ImmunityBio Inc IBRX
Restricted Stock Units · derivative
|
2025-02-22 | Option exercise | 114,329 | $0.00 | |
|
ImmunityBio Inc IBRX
Common Stock
|
2024-12-10 | Conversion | 103,710,088 | $1.94 | 201,197,571 |
|
ImmunityBio Inc IBRX
Amended and Restated Promissory Note · derivative
|
2024-12-10 | Other | $0.00 | ||
|
ImmunityBio Inc IBRX
Second Amended and Restated Convertible Promissory Note · derivative
|
2024-12-10 | Other | $505,000,000.00 | ||
|
ImmunityBio Inc IBRX
Convertible Promissory Note · derivative
|
2024-12-10 | Conversion | $0.00 | ||
|
ImmunityBio Inc IBRX
Convertible Promissory Note · derivative
|
2024-12-10 | Conversion | $0.00 | ||
|
ImmunityBio Inc IBRX
Common Stock
|
2024-12-10 | Conversion | 13,475,172 | $2.28 | 30,723,392 |
|
Cimarron Software Inc PBLA
8% Senior Convertible Note due 2025 · derivative
|
2024-11-15 | Buy | $9,150,000.00 | ||
|
Heliogen Inc HLGN
Common Stock
|
2024-02-15 | Buy | 442,298 | $1.52 | 672,293 |
|
ImmunityBio Inc IBRX
Convertible Promissory Note · derivative
|
2023-12-29 | Other | $30,000,000.00 | ||
|
ImmunityBio Inc IBRX
Amended and Restated Promissory Note · derivative
|
2023-12-29 | Other | $380,000,000.00 | ||
|
ImmunityBio Inc IBRX
Amended and Restated Convertible Promissory Note · derivative
|
2023-09-11 | Other | $0.00 | ||
| showing 20 of 54 most recent transactions | |||||